Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William A CarterfiledCriticalWilliam A Carter
Priority to MX2694687ApriorityCriticalpatent/MX168927B/en
Publication of MX168927BpublicationCriticalpatent/MX168927B/en
La presente invención se refiere a método para hacer celulas o fluido biológico resistentes a infección con retrovirus o virus lifotrópico de células T, porejemplo el virus del SIDA, mejorando su resistencia o mitigando el efecto de la infeción del mismo, caracterizado porque comprende mezclar o poner en contacto el fluido biológico o células con una cantidad efectiva de ácido ribonucléico de doble hebra(dhARN/dsRNA).The present invention relates to a method for making cells or biological fluid resistant to infection with retroviruses or lifotropic T-cell viruses, for example the AIDS virus, improving their resistance or mitigating the effect of infection thereof, characterized in that it comprises mixing or putting by contacting the biological fluid or cells with an effective amount of double stranded ribonucleic acid (dhRNA / dsRNA).
MX2694687A1987-03-091987-03-09
METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES
MX168927B
(en)
Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies
PHARMACEUTICAL PREPARATION WITH 3'-DESOXYTHYMIDIN-2'-EN (3'-DESOXY-2 ', 3'-DIDEHYDROTHYMIDINE) FOR TREATING PATIENTS WITH RETROVIRAL INFECTIONS.